Alembic Pharmaceuticals informs about press release

01 Mar 2023 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Docetaxel Injection USP, 20 mg/2 mL (10 mg/mL) Single-Dose Vial, and 80 mg/8 mL (10 mg/mL) and 160 mg/16 mL (10 mg/mL) Multiple-Dose Vials. It enclosed the press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

848.15 -4.15 (-0.49%)
29-Dec-2025 09:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.80
Dr. Reddys Lab 1269.35
Cipla 1513.50
Zydus Lifesciences 909.75
Lupin 2102.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×